Prasugrel, 99%

Name: Prasugrel, 99% | 150322-43-3
Brand: J&K Chemical
SKU: JK837013_10_MG
Price: 10.0 USD
Availability: OutOfStock

Cat. No JK837013_10_MG

Vendor: J&K Chemical

Product Information

Product Name

Prasugrel, 99%

Brand Name

J&K

Product Number

837013

CAS

150322-43-3

Molecular Formula

C20H20FNO3S

Molecular Weight

373.45

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

5-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl-4,5,6,7-tetrahydrothieno3,2-cpyridin-2-yl acetate

PubChem CID

6918456

IUPAC Name

5-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl-6,7-dihydro-4H-thieno3,2-cpyridin-2-yl acetate

InChI Key

DTGLZDAWLRGWQN-UHFFFAOYSA-N

SMILES

CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4

Safety Information

Precautionary Statement

P262

References Data Source From Pubchem

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

Publication Name: Cardiovascular Intervention and Therapeutics

Publication Date: 2026-03-03

DOI: 10.1007/s12928-026-01247-5

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Publication Date: 2026-03

DOI: 10.1007/s00063-025-01405-2

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Publication Date: 2026-03

DOI: 10.1007/s00063-025-01377-3

The solitaire AB stent for endovascular treatment of atherosclerotic stenosis of the basilar artery without snowplow phenomenon

Publication Name: Neuroradiology

Publication Date: 2026-02-28

DOI: 10.1007/s00234-026-03950-9

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026

Publication Name: Cardiovascular Intervention and Therapeutics

Publication Date: 2026-02-26

DOI: 10.1007/s12928-025-01229-z

Prasugrel, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

The solitaire AB stent for endovascular treatment of atherosclerotic stenosis of the basilar artery without snowplow phenomenon

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026

Prasugrel, 99%

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Prasugrel, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

The solitaire AB stent for endovascular treatment of atherosclerotic stenosis of the basilar artery without snowplow phenomenon

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026

Prasugrel, 99%

Related Product

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

#title#

Login

Register